Status:
COMPLETED
Optimizing Stress Ulcer Prophylaxis Practices and Reducing Associated Costs in Intensive Care Units: a Nonrandomized Controlled Study
Lead Sponsor:
Altinbas University
Conditions:
Stress Ulcer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is a prospectively designed, nonrandomized controlled study. It was conducted for six months at the EICU and GICU of a training and research hospital between 1 Jun 2023 and 1 December 2023.
Detailed Description
The study involved GICU patients as the standard care services observation group (OG). The use of SUP in the GICU was only monitored and noted. In the EICU, patients were identified as part of the rec...
Eligibility Criteria
Inclusion
- The inclusion criteria were patients aged ≥18 years and hospitalized for ≥24 hours in the EICU/GICU.
Exclusion
- Patients with a history of stomach cancer, admission to the ICU because of GI bleeding, subtotal/total gastrectomy, or receiving a proton pump inhibitor for therapeutic purposes were excluded from the study.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT06586333
Start Date
June 1 2023
End Date
December 1 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prof. Dr. Cemil Taşcıoğlu City Hospital, Clinical Pharmacy, İstanbul, Türkiye,
Istanbul, Turkey, Turkey (Türkiye), 34147